Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale - Concepedia

Concepedia

Publication | Closed Access

Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale

455

Citations

25

References

2010

Year

Renato D. Lópes, John H. Alexander, Sana M. Al‐Khatib, Jack Ansell, Raphael Diaz, J. Donald Easton, Bernard J. Gersh, Christopher B. Granger, Michael Hanna, John D. Horowitz,

American Heart Journal

ThrombosisVenous ThrombosisCardiovascular DiseaseStrokeAtherosclerosisOther Thromboembolic EventsMedicinePlatelet AntagonistFibrinolysisPharmacotherapyNeurologyAtrial FibrillationCerebral Blood FlowPublic HealthPharmacologyAnticoagulantCardiology

References

	Year	Citations

Page 1

Page 1